Document Detail

Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development.
MedLine Citation:
PMID:  23887647     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Model-based drug development (MBDD) is accepted as a vital approach in understanding patients' drug-related benefit and risk by integrating quantitative information integration from diverse sources collected throughout drug development.(1) This perspective introduces the activities of the Drug and Disease Model Resources (DDMoRe) consortium, founded in 2011 through the Innovative Medicines Initiative Joint Undertaking (IMI-JU)(2) as a European public-private partnership to address a lack of common tools, languages, and standards for modeling and simulation (M&S) to improve model-based knowledge integration.CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e34; doi:10.1038/psp.2013.10; advance online publication 20 March 2013.
L Harnisch; I Matthews; J Chard; M O Karlsson
Related Documents :
24445487 - Potential drug targets for calcific aortic valve disease.
24087867 - Chapter 5. russian media narratives about young drug users.
10308117 - New prescription for drug regulation.
11527007 - Alemtuzumab (millennium/ilex).
12678747 - The prodrugs of 5-fluorouracil.
7651977 - Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 3....
Publication Detail:
Type:  Journal Article     Date:  2013-03-20
Journal Detail:
Title:  CPT: pharmacometrics & systems pharmacology     Volume:  2     ISSN:  2163-8306     ISO Abbreviation:  CPT Pharmacometrics Syst Pharmacol     Publication Date:  2013  
Date Detail:
Created Date:  2013-07-26     Completed Date:  2013-07-26     Revised Date:  2014-11-03    
Medline Journal Info:
Nlm Unique ID:  101580011     Medline TA:  CPT Pharmacometrics Syst Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e34     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell d...
Next Document:  Anti-Inflammatory Activity of N-(3-Florophenyl)ethylcaffeamide in Mice.